ReviewClinical and translational science2026

Clinical Pharmacology Perspective on Direct-To-Subcutaneous Dosing of T Cell Engagers in Oncology First-In-Human Studies.

Wenlian Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.